ResMed Current Ratio 2006-2018 | RMD

Current and historical current ratio for ResMed (RMD) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending September 30, 2018 was 2.58.
ResMed Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $1.09B $0.42B 2.58
2018-06-30 $1.07B $0.51B 2.09
2018-03-31 $1.60B $0.46B 3.48
2017-12-31 $1.75B $1.36B 1.29
2017-09-30 $1.66B $0.35B 4.72
2017-06-30 $1.64B $0.36B 4.57
2017-03-31 $1.61B $0.34B 4.77
2016-12-31 $1.52B $0.68B 2.23
2016-09-30 $1.48B $0.62B 2.38
2016-06-30 $1.42B $0.64B 2.23
2016-03-31 $1.40B $0.29B 4.89
2015-12-31 $1.35B $0.27B 5.09
2015-09-30 $1.53B $0.26B 5.96
2015-06-30 $1.41B $0.27B 5.28
2015-03-31 $1.55B $0.26B 6.06
2014-12-31 $1.56B $0.26B 6.00
2014-09-30 $1.54B $0.25B 6.04
2014-06-30 $1.56B $0.27B 5.77
2014-03-31 $1.56B $0.25B 6.33
2013-12-31 $1.56B $0.24B 6.44
2013-09-30 $1.56B $0.61B 2.55
2013-06-30 $1.45B $0.57B 2.52
2013-03-31 $1.58B $0.58B 2.72
2012-12-31 $1.53B $0.25B 6.09
2012-09-30 $1.45B $0.25B 5.73
2012-06-30 $1.36B $0.25B 5.38
2012-03-31 $1.33B $0.26B 5.15
2011-12-31 $1.25B $0.23B 5.46
2011-09-30 $1.14B $0.23B 5.06
2011-06-30 $1.29B $0.21B 6.19
2011-03-31 $1.20B $0.19B 6.28
2010-12-31 $1.15B $0.25B 4.64
2010-09-30 $1.07B $0.29B 3.73
2010-06-30 $0.99B $0.31B 3.15
2010-03-31 $1.03B $0.33B 3.17
2009-12-31 $0.93B $0.24B 3.86
2009-09-30 $0.94B $0.29B 3.22
2009-06-30 $0.85B $0.27B 3.17
2009-03-31 $0.73B $0.23B 3.19
2008-12-31 $0.71B $0.22B 3.16
2008-09-30 $0.69B $0.18B 3.90
2008-06-30 $0.74B $0.19B 3.84
2008-03-31 $0.72B $0.14B 5.06
2007-12-31 $0.69B $0.16B 4.24
2007-09-30 $0.67B $0.18B 3.71
2007-06-30 $0.67B $0.20B 3.30
2007-03-31 $0.64B $0.20B 3.18
2006-12-31 $0.59B $0.16B 3.61
2006-09-30 $0.52B $0.12B 4.27
2006-06-30 $0.51B $0.13B 3.95
2006-03-31 $0.43B $0.11B 3.91
2005-12-31 $0.40B $0.26B 1.57
2005-09-30 $0.37B $0.23B 1.61
2005-06-30 $0.36B $0.22B 1.65
2005-03-31 $0.36B $0.09B 4.22
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.492B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00